TY - JOUR
T1 - Concanavalin A alters the turnover rate of tyrosine aminotransferase in cultured hepatoma cells
AU - Donohue, Terrence M.
AU - Lee, Kai Lin
AU - Kenney, Francis T.
N1 - Funding Information:
This research was supported jointly by National Institutes of Health grant R01 GM 25210 and by the Office of Health and Environmental Research, U.S. Department of Energy under contract W-7405-eng-26 with the Union Carbide Corporation. T.M.D. is the recipient of National Institutes of Health Postdoctoral Fellowship 5 F32 CA 06178. We thank Mr. William Wasilenko of the University of Tennessee-Oak Ridge Graduate School of Biomedical Sciences for aid in these experiments.
PY - 1982/9/13
Y1 - 1982/9/13
N2 - Concanavalin A added to monolayer cultures of Reuber H-35 hepatoma cells caused a rapid inactivation of tyrosine aminotransferase (l-tyrosine:2-oxoglutarate aminotransferase, E.C. 2.6.1.5) and loss of reactivity with antibody against the native, dimeric enzyme. Analysis of treated cells with an antibody raised against carboxymethylated, denatured enzyme showed that the inactivated enzyme was reactive with this reagent, which does not react with the native enzyme. Subsequent addition of α-methyl-d-mannopyranoside to remove concanavalin A restored both enzyme activity and reactivity to antibody against native enzyme. After long-term treatment with concanavalin A, the restored enzyme levels were significantly higher than in controls treated with the sugar but not the lectin. Analysis of the turnover of the enzyme by two methods revealed that the rate of its degradation is reduced about 2-fold in concanavalin A-treated cells. Treatment with H-35 cells with concanavalin A thus effects an alteration in conformation of tyrosine aminotransferase, rendering it somewhat less sensitive to intracellular degradation.
AB - Concanavalin A added to monolayer cultures of Reuber H-35 hepatoma cells caused a rapid inactivation of tyrosine aminotransferase (l-tyrosine:2-oxoglutarate aminotransferase, E.C. 2.6.1.5) and loss of reactivity with antibody against the native, dimeric enzyme. Analysis of treated cells with an antibody raised against carboxymethylated, denatured enzyme showed that the inactivated enzyme was reactive with this reagent, which does not react with the native enzyme. Subsequent addition of α-methyl-d-mannopyranoside to remove concanavalin A restored both enzyme activity and reactivity to antibody against native enzyme. After long-term treatment with concanavalin A, the restored enzyme levels were significantly higher than in controls treated with the sugar but not the lectin. Analysis of the turnover of the enzyme by two methods revealed that the rate of its degradation is reduced about 2-fold in concanavalin A-treated cells. Treatment with H-35 cells with concanavalin A thus effects an alteration in conformation of tyrosine aminotransferase, rendering it somewhat less sensitive to intracellular degradation.
KW - (Hepatoma cell)
KW - Concanavalin A
KW - Protein turnover
KW - Tyrosine aminotransferase
UR - http://www.scopus.com/inward/record.url?scp=0020412626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020412626&partnerID=8YFLogxK
U2 - 10.1016/0167-4889(82)90028-3
DO - 10.1016/0167-4889(82)90028-3
M3 - Article
C2 - 6127118
AN - SCOPUS:0020412626
SN - 0167-4889
VL - 721
SP - 94
EP - 100
JO - BBA - Molecular Cell Research
JF - BBA - Molecular Cell Research
IS - 1
ER -